Clinical Trial Update: A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL) [Phase 4]

View source ↗

Summary

A Phase 4 study sponsored by Janssen banked samples from Crohn's disease and ulcerative colitis patients to identify biomarkers that may predict development of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Hepatosplenic T-cell Lymphoma
• Ulcerative Colitis

Snippet

Sponsor: Janssen Scientific Affairs, LLC | Conditions: Hepatosplenic T-Cell Lymphoma | Phase 4 | Status: COMPLETED | Results posted: 2021-03-04